Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ICMT | O60725 | 15/20 | 0.83 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20390363 | 0.92 | ICMT (0.78) | ICMTMAPTALDH1A1MEN1TRPA1 | |
| SCHEMBL12466774 | 0.90 | ICMT (0.72) | ICMTMAPTALDH1A1 | |
| SCHEMBL5427483 | 0.87 | ICMT (0.66) | ICMTMAPTALDH1A1 | |
| SCHEMBL14596313 | 0.87 | ICMT (0.70) | ICMTMAPTALDH1A1 | |
| SCHEMBL3423544 | 0.86 | ICMT (0.75) | ICMTMAPTALDH1A1TRPA1 | |
| SCHEMBL3423548 | 0.86 | ICMT (0.75) | ICMTMAPTALDH1A1TRPA1 | |
| SCHEMBL13253017 | 0.86 | ICMT (0.75) | ICMTMAPTALDH1A1TRPA1 | |
| SCHEMBL20389919 | 0.86 | ICMT (0.78) | ICMTMAPTALDH1A1 | |
| SCHEMBL13252994 | 0.86 | ICMT (0.64) | ICMTMAPTALDH1A1 | |
| SCHEMBL12792939 | 0.85 | MAPT (0.68) | ICMTMAPTALDH1A1MEN1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1899480-A4 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS | SIGNUM BIOSCIENCES INC (US) | 2009-04-22 | — | — | EP | claimed |
| EP-1899480-A1 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS | SIGNUM BIOSCIENCES, INC. (US) | 2008-03-19 | — | — | EP | claimed |
| WO-2006135894-A1 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS | SIGNUM BIOSCIENCES, INC. (US) | 2006-12-21 | — | — | WO | claimed |
| US-5202456-A | Anticarcinogenic agents; methylating transferase inhibitors; farnesyl or geranyl sulfur-, oxygen or selenium-containing derivatives | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1993-04-13 | — | — | US | claimed |
| US-20090155186-A1 | Compositions and methods for treating inflammatory conditions | SIGNUM BIOSCENCES, INC. (NJ) | 2009-06-18 | — | — | US | disclosed |
| EP-1899480-A4 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS | SIGNUM BIOSCIENCES INC (US) | 2009-04-22 | — | — | EP | disclosed |
| EP-1899480-A1 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS | SIGNUM BIOSCIENCES, INC. (US) | 2008-03-19 | — | — | EP | disclosed |
| WO-2006135894-A1 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS | SIGNUM BIOSCIENCES, INC. (US) | 2006-12-21 | — | — | WO | disclosed |
| US-5202456-A | Anticarcinogenic agents; methylating transferase inhibitors; farnesyl or geranyl sulfur-, oxygen or selenium-containing derivatives | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1993-04-13 | — | — | US | disclosed |
| WO-1992018465-A2 | COMPOUNDS FOR INHIBITION OF PROTEIN METHYLATION | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1992-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090155186-A1 | Compositions and methods for treating inflammatory conditions | TNF, TRAF6, RELA | ICMT 3602/4885MAPT 3196/4885ALDH1A1 2832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.